AXL-specific single domain antibodies show diagnostic potential and antitumor activity in acute myeloid leukemia

被引：0
|
作者：
Vandewalle, Niels
Satilmis, Hatice
Verheye, Emma M.
Fan, Rong
Wang, Yanmeng
De Groof, Timo W.
Kerre, Tessa
De Beule, Nathan
De Becker, Ann
De Bruyne, Elke
Menu, Eline
Vanderkerken, Karin
Breckpot, Karine
Devoogdt, Nick
De Veirman, Kim
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4181
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4181
引用
收藏
页数：2
相关论文
共 50 条
  • [1] AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
    Vandewalle, Niels
    Satilmis, Hatice
    Verheye, Emma
    Fan, Rong
    Wang, Yanmeng
    De Groof, Timo W. M.
    Bridoux, Jessica
    Kerre, Tessa
    De Beule, Nathan
    De Becker, Ann
    De Bruyne, Elke
    Menu, Eline
    Vanderkerken, Karin
    Breckpot, Karine
    Devoogdt, Nick
    De Veirman, Kim
    THERANOSTICS, 2024, 14 (07): : 2656 - 2674
  • [2] Prognostic Significance and Target Potential of Axl in Acute Myeloid Leukemia
    Schultze, Alexander
    Ben-Batalla, Isabel
    Heuser, Michael
    Weber, Kristoffer
    Erdmann, Robert
    Holland, Sacha
    Sawall, Stefanie
    Fritz, Helena
    Tjwa, Marc
    Schmidt, Thomas
    Fiedler, Walter
    Fehse, Boris
    Dahlback, Bjorn
    Pantel, Klaus
    Krauter, Juergen
    Ganser, Arnold
    Bokemeyer, Carsten
    Loges, Sonja
    BLOOD, 2011, 118 (21) : 428 - 428
  • [3] The potential role of Bi-specific antibodies in acute myeloid leukemia
    Yilmaz, Musa
    Ravandi, Farhad
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2020, 33 (04)
  • [4] Axl inhibition: a potential road to a novel acute myeloid leukemia therapy?
    Janning, Melanie
    Ben-Batalla, Isabel
    Loges, Sonja
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (02) : 135 - 138
  • [5] Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer
    Koopman, Louise A.
    Terp, Mikkel G.
    Zom, Gijs G.
    Janmaat, Maarten L.
    Jacobsen, Kirstine
    Gresnigt-van den Heuve, Elke
    Brandhorst, Marcel
    Forssmann, Ulf
    de Bree, Freddy
    Pencheva, Nora
    Lingnau, Andreas
    Zipeto, Maria A.
    Parren, Paul W. H., I
    Breij, Esther C. W.
    Ditzels, Henrik J.
    JCI INSIGHT, 2019, 4 (21)
  • [6] Antitumor activity of bortezomib alone and in combination with trail in human acute myeloid leukemia
    Conticello, Concetta
    Adamo, Luana
    Vicari, Luisa
    Giuffrida, Raffaella
    Iannolo, Gioacchin
    Anastasi, Gabriele
    Caruso, Laura
    Moschetti, Gaetano
    Cupri, Alessandra
    Palumbo, Giuseppe Antonio
    Gulisano, Massimo
    De Maria, Ruggero
    Giustolisi, Rosario
    Di Raimondo, Francesco
    ACTA HAEMATOLOGICA, 2008, 120 (01) : 19 - 30
  • [7] Antitumor activity of bortezomib alone and in combination with trail in human acute myeloid leukemia
    Conticello, C. M. S.
    Adamo, L.
    Vicari, L.
    Giuffrida, R.
    Iannolo, G.
    Moschetti, G.
    Anastasi, G.
    Palumbo, G. A.
    De Maria, R.
    Giustolisi, R.
    Di Raimondo, F.
    Gulisano, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 13 - 13
  • [8] Development of an Axl/Mer Dual Inhibitor, ONO-9330547: Promising Single Agent Activity in an Acute Myeloid Leukemia (AML) Model
    Yasuhiro, Tomoko
    Yoshizawa, Toshio
    Fujikawa, Ryu
    Tanaka, Kohei
    Koike, Tomoya
    Kawabata, Kazuhito
    BLOOD, 2014, 124 (21)
  • [9] Alkynyl nicotinamides show antileukemic activity in drug-resistant acute myeloid leukemia
    Ramdas, Baskar
    Dayal, Neetu
    Pandey, Ruchi
    Larocque, Elizabeth
    Kanumuri, Rahul
    Pasupuleti, Santhosh Kumar
    Liu, Sheng
    Kanellopoulou, Chrysi
    Chu, Elizabeth Fei Yin
    Mohallem, Rodrigo
    Virani, Saniya
    Chopra, Gaurav
    Aryal, Uma K.
    Lapidus, Rena
    Wan, Jun
    Emadi, Ashkan
    Haneline, Laura S.
    Holtsberg, Frederick W.
    Aman, M. Javad
    Sintim, Herman O.
    Kapur, Reuben
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (12):
  • [10] Antitumor activity of Bortezomib alone and in combination with TRAIL in human acute myeloid leukemia.
    Conticello, Concetta
    Adamo, Luana
    Vicari, Luisa
    Giuffrida, Raffaella
    Iannolo, Gioacchin
    Anastasi, Gabriele
    Palumbo, Giuseppe A.
    Gulisano, Massimo
    De Maria, Ruggero
    Giustolisi, Rosario
    Di Raimondo, Francesco
    BLOOD, 2007, 110 (11) : 144B - 144B
12345